Ellansé M (2x1ml)
The lowest price of the product zł749.00 in day 02.01.2026
Ellansé M is a sterile, apyrogenic, fully absorbable subcutaneous implant, classified as a tissue stimulator with a prolonged duration of action. It consists of synthetic polycaprolactone (PCL) microspheres suspended in a carboxymethylcellulose (CMC) based gel carrier. The device exhibits a dual-phase mechanism of action: immediate mechanical correction and secondary induction of neocollagenesis.
mechanism of action
-
initial phase (mechanical correction): The CMC gel carrier (70% by volume) provides immediate interstitial filling and mechanical correction of volume deficits directly after injection
-
stimulation phase (neocollagenesis): The PCL microspheres (30% by volume, size 25-50 microns) act as a scaffold for fibroblasts, inducing the production of endogenous Type I collagen. This process allows for the restoration of the extracellular matrix (ECM) structure and long-term improvement of the skin's biomechanical parameters
-
bioresorption: The implant undergoes complete degradation into water and carbon dioxide (via the Krebs cycle), ensuring long-term safety
indications and intended use
The device is intended for administration via injection by authorized medical personnel to:
-
correction of volume deficits: fill nasolabial folds, marionette lines, and atrophic scars
-
facial contour modeling: improve the projection of cheeks, jawline, and temples
-
structural wrinkle reduction: reduce forehead and perioral wrinkles
-
tissue biostimulation: restore density and elasticity to skin affected by the aging process
injection technique
-
depth: subcutaneous layer or deep layers of the dermis
-
technique: linear-retrograde (stringing), fanning technique
-
tools: recommended 27G 20mm needle or cannula (depending on the area)
composition
-
Polycaprolactone (PCL) microspheres: 30% (stimulating spheres)
-
Carboxymethylcellulose (CMC) gel carrier: 70% (USP carrier)
contraindications
-
pregnancy and lactation
-
active autoimmune diseases, uncontrolled diabetes, history of neoplastic disease
-
viral, bacterial, or inflammatory infections in the treatment area
-
known hypersensitivity to any component of the preparation
-
presence of permanent fillers in the planned injection area
-
use of anticoagulants (relative contraindication)
post-treatment recommendations
-
do not massage or press the injection area for at least 24 hours (unless otherwise directed by a physician)
-
avoid extreme temperatures (sauna, solarium, sun exposure) and use SPF 50+ photoprotection for a period of 14 days
duration of effect
- up to 24 months (depending on the product variant and individual patient characteristics)
contents
- 2 pre-filled syringes (1 ml each)
|
PRE-FILLED SYRINGE |
||
|
The product may only be used by professionals. By making a purchase, you declare that you are a doctor or cosmetologist trained in aesthetic medicine. |
||